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Abstract 
Background: Human papillomavirus (HPV) is arguably the most prevalent sexually transmitted 
infection, and has been linked to a variety of health complications including cervical cancer, anal cancer, 
and anogenital warts. The HPV vaccine can prevent these health complications, but few studies have 
investigated the specific factors that impact HPV vaccine uptake. Methods: Two hundred seventy-five 
male and female high school students were surveyed in an ethnically diverse school district in southern 
California regarding HPV vaccine uptake and perceptions. Results: Less than one third of students 
reported their physician had discussed HPV vaccine with them, and fewer still for males (p<0.01). 
Students who did discuss HPV vaccination with their physician were significantly more likely to get 
vaccinated (p<0.01). Conclusion: These findings suggest the merit of the physician taking on a more 
active role during office visits to promote knowledge of HPV and HPV vaccine to all youth in this age 
group. 
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Introduction 
 
According to the Centers for Disease Control 
and Prevention (CDC), human papillomavirus 
(HPV) is one of the most common sexually 
transmitted infections (STIs) in the United States 
(CDC, 2012; Lambert, 2001; Friedman & 
Sheppard, 2007).  The CDC estimates 
approximately 79 million Americans are 
currently infected with HPV, with an overall 
prevalence of 31.9% in 2013 (CDC, 2012; 
Damin, Ziegelmann, & Damin, 2013; Hairiri et 
al., 2011). With 14 million new infections each 
year, HPV-related cancers have become a 
growing concern. In addition to causing the vast 
majority of cervical cancers, HPV is linked to 
approximately one-third of penile cancers, two-
thirds of mouth and throat cancers, and over 
90% of cases of anal cancer and genital warts 
(CDC, 2011; Beatty, O'Connel, Ashikaga, & 
Cooper, 2003). Data collected by the National 
Institutes of Health (NIH) from 2003 to 2007 
was used to estimate that the number of cervical 
cancer related deaths will be approximately 2.4 
per 100,000 women per year within the United 
States (U.S. Department of Health and Human 
Services, 2013).  
 
Adolescent Exposure 
The CDC Youth Risk Behavior Surveillance 
survey reported that in 2013, 19.6% of 9th grade, 
29.4% of 10th grade, 40.2% of 11th grade, and 
49.3% of 12th grade students were sexually 
active (CDC, 2014). The U.S. Department of 
Health and Human Services (2014) estimates 
that adolescents age 15-24 account for 
approximately 50% of new STI cases each year. 
Adolescents’ high STI contraction and sexual 
activity rates place them at high risk for HPV 
later in life.  As such, the Advisory Committee 
on Immunization Practices (ACIP) recommends 
that all adolescents should begin receiving the 
HPV vaccine around 11-12 years of age (Hirth, 
Tan, Wilkinson, & Berenson, 2012). It is 
recommended for females ages 9 to 26 and 
males ages 11 to 26 to complete the three-shot 
series as soon as possible. The CDC also 
promotes early vaccination due to the vaccines’ 
increased effectiveness prior to HPV exposure. 
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Vaccine 
The HPV vaccine is a safe and effective way to 
protect against HPV types 6, 11, 16, and 18, and 
is effective in reducing HPV prevalence (Jin, 
Lipold, Sikon, & Rome, 2013). Research 
conducted on the vaccine’s effectiveness for 
females ages 14-19 has found that HPV 
prevalence has decreased from 11.5% in 2003-
2006 to 5.1% in 2007-2010 (Markowitz et al., 
2013). While effective, HPV vaccine initiation 
and completion rates are still relatively low. 
Currently, the HPV vaccine is not grouped with 
other childhood vaccines and must be requested.  
One study examined HPV vaccine initiation and 
completion rates for 271,976 young females 
between the ages of 13 to 18 in the United States 
, and found that completion rates decreased from 
55% to 21% from 2006 to 2009 (Hirth, Tan, 
Wilkinson, & Berenson, 2012). Additionally, 
research suggests that a lack of patient 
information and education can negatively impact 
HPV vaccine uptake and acceptance (Sparks & 
Villagran, 2010). Thus, education regarding 
vaccination has become an increasingly 
important tool for the prevention of chronic 
HPV and cervical cancer (CDC, 2012; Beatty et 
al., 2003). 
 
The prevalence of HPV is largely associated 
with its asymptomatic nature as well as a lack of 
HPV knowledge. Controversies have arisen due 
to the newness of the vaccine, the sexually-
transmitted nature of HPV, non-transmissibility 
of HPV through non-sexual contact, and the 
high price of the vaccine (Colgrove, Abiola, & 
Mello, 2010). Foundational theories of health 
behavior suggest the salience of some key 
intrapersonal factors that could decrease the 
chances that an individual might engage in a 
preventative health behavior, including low 
levels of perceptions of the severity of an illness 
and ones’ susceptibility to it, a lack of 
perceiving benefits to undertaking a preventative 
health action, and strongly perceiving barriers to 
undertaking a preventive health action 
(Rosenstock, 1974). Moreover, each of these 
factors might be precipitated by a lack of 
knowledge regarding the health consequences of 
failing to engage in a preventive action or of the 
benefits of engaging in the preventive health 
behavior. Additionally, the Theory of Planned 
Behavior suggests that perceived normative 
beliefs regarding whether or not important 
referents such as friends and family approve of 
engaging in a health behavior, and as well one’s 
motivation to comply with these norms relates to 
one’s intention to engage in health relevant 
behavior (Ajzen, 1991).   
 
If physicians actively adopt and promote HPV 
education campaigns, both the adolescents and 
their parents may feel more confident in the 
HPV vaccine. Gravitt (2011) noted that mothers 
wanted extensive information regarding the 
HPV vaccine, in addition to evidence linking 
HPV to cervical cancer, long before they would 
even consider vaccinating their children. 
Mergler and colleagues (2013) found that 
parents and their children’s health care providers 
have similar views regarding vaccinations. As a 
result, healthcare providers may have a 
significant impact on a parent’s openness to 
initiate a vaccine series. As such, we 
investigated factors that impact the initiation and 
completion rates of the HPV vaccine among 
high school students. The purpose of this project 
was to determine adolescents’ knowledge and 
interest in the HPV vaccine, as well as the role 
of the physician in HPV vaccine uptake among 
adolescents.  
 
Methods 
 
Sample 
This study included a convenience sample of 
students in one large ethnically diverse high 
school in southern California. The high school 
was selected based on its generalizability to 
Orange County’s demographics. Students from 
eight classes (n=275) were surveyed during one 
instructional period. In order to participate in the 
survey, students must have been between the 
ages of 13 and18. Both male and female students 
were surveyed. Participating classes were 
chosen based on grade level, class subject, and 
the teacher’s level of comfort in having the 
survey administered in his or her class.  
 
Procedures 
The principal’s approval was received from the 
participating high school prior to applying for 
and receiving IRB approval. The IRB waived 
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the need for signed parent permission, as no 
identifiers were collected. Participating 
classrooms were confirmed prior to IRB 
approval via email. Before administration of the 
survey, participating classrooms were visited 
and and 
informational courtesy letter was sent home with 
each child. The lead researcher administered the 
survey according to a script for each class. 
Parents who did not want their child to 
participate were asked to e-mail the instructor of 
the course. Students who did not participate 
were asked to turn the survey over, whereas 
students who chose to participate gave verbal 
consent and proceeded to complete the survey. 
Upon completion of the survey, raffle tickets 
were handed out to participating students. A 
raffle drawing was performed in which one 
student from each class were given a gift card 
valued at $5.00.  
 
Measures 
The outcomes of interest were whether the 
participant had received the vaccine, planned to 
receive the vaccine, and if they were interested 
in learning more about HPV and the HPV 
vaccine. The survey measures were based on a 
previous HPV study (Brown, Carcamo, Blas, 
Valderrama, & Halsey, 2010). Survey questions 
pertaining to sexual activity were not asked 
because the sample population consisted of 
children.  Demographic variables included 
gender, age, race, religion of the student, and 
religion of the parent. 
 
Analyses  
Descriptive statistics were conducted on the 
gender, ethnicity, religion of the student, religion 
of the parent, and age (see Table 1). Chi-square 
tests were conducted to determine if there were 
gender differences in receiving the vaccine and 
physician discussing the vaccine with a 
physician. Vaccine dosage received was 
stratified by gender, heard of HPV, age, and 
race; chi-square tests were run to determine 
whether vaccine dose varied by these 
background characteristics (Table 2). Binary 
logistic regression models were run to analyze 
the relationship between demographic 
characteristics and the following variables: heard 
of HPV, received the vaccine, plans to receive 
the vaccine, interest in learning, and physician 
discussed the vaccine (Table 3). Another set of 
binary logistic regression models were run to 
determine whether the physician discussing the 
vaccine, prior HPV knowledge, and plans on 
receiving the vaccine were associated with the 
likelihood of receiving the HPV vaccine series. 
Another binary logistic regression model was 
run to determine whether a physician discussing 
the vaccine, or a student’s interest in the 
vaccine, would encourage students to plan on 
receiving the vaccine. A similar model was run 
used to evaluate the relationship of a physician 
discussing the vaccine with children’s interest in 
learning more about HPV and the HPV vaccine. 
Finally, a linear regression was run to analyze 
whether students who had a physician discuss 
the HPV vaccine, had heard of HPV, or planned 
on receiving the vaccine, were more likely to 
 
Table 1 
 
Demographic Characteristics of the Sample 
(n=275) 
 n  %  
Gender   
Male 160 58.2 
Female 114 41.5 
Race   
Asian 135 49.1 
White 93 33.8 
American Indian or 
 Alaska  Native 
11 4.0 
Black and African 
 American 
7 2.5 
Native Hawaiian or  
 Pacific Islander 
5 1.8 
Other 21 7.6 
Religion of Student   
Catholic or Christian 107 38.9 
Atheist or Agnostic 110 40.0 
Muslim 21 7.6 
Buddhist 6 2.2 
Hindu 5 1.8 
More than one/other 5 1.8 
Jewish 9 3.3 
Religion of Parents   
            Catholic or Christian 136 49.5 
Atheist or Agnostic 58 21.1 
Muslim 26 9.5 
Buddhist 15 5.5 
Hindu 10 3.6 
More than one/other 10 3.6 
Jewish 9 3.3 
Mean Age (SD) 16.13  (1.175) 
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receive all three doses.  
 
Table 2 
 
HPV Vaccine Dose Received by Demographic Characteristics 
 1-2 HPV 
vaccine 
doses 
3 HPV 
vaccine 
doses 
 Did not 
know/ 
Other 
Total 
responses 
χ2  
(p)  
 n (%) n (%) n (%) n (%)  
All Participants 
    - 
N, (%) 16 (11.7) 26 (19.0) 95 (69.3) 137 (100.0)  
Gender 
    18.53 (0.001) 
     Male 9 (12.9) 4 (5.7) 57 (81.4) 70 (51.1)  
     Female 7 (10.4) 22 (32.8) 38 (56.7) 67 (48.9)  
Age (years) 
    26.45 (0.151) 
    13-16 7 (8.6) 16 (19.8) 58 (71.6) 81 (59.1)  
    17-18 9 (17.0) 10 (18.9) 34 (64.2) 53 (38.7)  
Race 
    41.22 (0.003) 
    Asian 5 (7.8) 7 (10.9) 52 (81.3) 64 (46.7)  
    White 7 (14.3) 15 (30.6) 27 (55.1) 49 (35.8)  
    American Indian         
Alaska Native 1 (16.7) 1 (16.7) 4 (66.7) 6 (4.4)  
    Black/African 
American 1 (0.25) 1 (0.25) 2 (0.5) 4 (2.9)  
    Native Hawaiian/ 
Pacific Islander 1 (50.0) 1 (50.0) 0 (0.0) 2 (1.5)  
Other 0 (0.0) 1 (9.1) 10 (90.9) 11 (8.0)  
Student Religion 
    18.76 (0.765) 
    Christian 3 (5.8) 10 (19.2) 39 (75.0) 52 (38.0)  
    Non-Christian 12 (15.2) 15 (19.0) 52 (65.8) 79 (57.7)  
Parent Religion 
    23.60 (0.485) 
    Christian 7 (10.6) 12 (18.2) 47 (71.2) 66 (48.2)  
    Non-Christian 7 (10.8) 13 (20.0) 45 (69.2) 65 (47.4)  
 
All tests were controlled for possible 
confounding variables, which included gender, 
age, race, religion of the student, and religion of 
the parent. Finally, descriptive statistics were 
also reported for the survey’s open-ended 
questions (Table 4).  
 
 
Results 
 
A total of 275 students were surveyed, aged 13 
to 18, with a mean age of 16.13 (SD= 1.175). 
Demographic data regarding the age, gender, 
race, religion of student, and religion of parent 
were collected (Table 1). Over half (n=164, 
59.6%) of participants reported not having heard 
of HPV before. More male (n=99) students 
reported not having heard about HPV compared 
to female (n=65) students (Table 3, p<0.01). The 
majority (70.2%, n=193) of students reported 
not having discussed the vaccine with their 
physician. One hundred and ten (40.0%) 
students planned to receive the HPV vaccine (62 
males and 48 females), with no significant 
gender (p>0.2) or age (p>0.9) differences.  
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Table 3 
 
Logistic Regression of Outcome Variables on Demographic Characteristics 
 
Heard of 
HPV 
OR (p) 
Received the 
Vaccine 
OR (p) 
Plan to 
receive the 
vaccine 
OR (p) 
Interest in 
learning 
more 
OR (p) 
Physician 
discussed 
the vaccine 
OR (p) 
Age 1.63 (0.00) 1.121 (0.39) 1.003 (0.98) 1.078 (0.51) 1.339 (0.06) 
Gender 1.34 (0.28) 3.108 (0.00) 1.209 (0.50) 0.775 (0.34) 6.064 (0.00) 
Ethnicity 0.939 (0.46) 1.1018 (0.85) 1.158 (0.09) 1.109 (0.32) 0.994 (0.96) 
Student's 
religion 0.946 (0.61) 1.126 (0.31) 0.928 (0.50) 1.100 (0.37) 0.955 (0.72) 
Parent's 
religion† 1.062 (0.54) 0.891 (0.27) 0.988 (0.90) 0.969 (0.75) 0.865 (0.22) 
† Indicates that Christian is being compared to non-Christian religious faiths 
 
Eighty six (31.3%) students reported receiving 
the HPV vaccine, and of these, 9.4% (n=26) 
reported receiving all 3 doses (Table 2). The 
majority of students (85.7% n=233) did not 
know if they had received the vaccine or how 
many doses they had received (Table 2).  Chi-
square tests found that females and students who 
labeled their race as “white”, were more likely to 
complete the vaccine series (Table 2, p <0.001 
and p<0.03, respectively). The binary logistic 
regression model found that older students were 
more likely to have heard of HPV (Table 3, 
p<0.001, OR =1.625). Females were more likely 
to initiate the vaccine series (Table 3, p<0.001, 
OR=3.108), and to have a physician discuss the 
vaccine with them (Table 3, p<0.001, 
OR=6.064).   Additionally, while controlling for 
gender, age, race, student’s religion, and 
parent’s religion, it was found that students who 
had heard of HPV, or had a physician discuss 
the vaccine with them were more likely to 
receive the vaccine (p<0.001, OR= 13.222 and 
p<0.001, OR= 8.065, respectively).  
 
A linear regression model found a significant 
relationship between physician discussing the 
vaccine and the following variables: heard of 
HPV, interested in learning more about HPV, 
and vaccine dose received. Students who had a 
physician discuss the vaccine with them were 
more likely to have heard of HPV, were more 
interested in learning more about HPV, and had 
received a more complete vaccine dose 
(p<0.001). A lack of vaccine knowledge, among 
other factors, was the main reason students 
reported for not receiving the HPV vaccine 
(Table 4). Additionally, the main question 
students had regarding HPV and the HPV 
vaccine was “what is it?” (Table 4). 
 
Discussion 
 
The findings of this study emphasize the 
importance of promoting the role of physicians 
within HPV education campaign. Active 
participation by a physician may result in greater 
adolescent HPV knowledge, as well as increases 
in vaccine uptake and initiation rates. Our 
convenience sample included youth of various 
ethnic backgrounds, and moreover, the school in 
which our sample was drawn was given a high 
diversity rank among California high schools 
(Los Angeles Times, 2011). According to state 
data, the student body was 51.0 % Asian, 34.9% 
White, 6.9% Latino, 2.1% Black, and 5.2% other 
(Los Angeles Times, 2011). These percentages 
are approximately representative of the school 
district in which the study sample was drawn, 
which consists of 43.3% Asian, 35.6% white, 
10.2% Latino, 2.3 % Black, and 8.5 % other 
(California Department of Education, 2012). Our 
sample, which appeared to represent the 
population of interest had low awareness of 
health risks associated with HPV. 
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Table 4 
 
What Students Reported Wanting to Learn about HPV and Reasons for Lack of 
Interest 
Want to learn(%*) Why not interested(%*) 
“What is it”? 91 (43.3) I don’t know what HPV is 65 (37.1) 
“I am interested in learning more 
about the vaccine/prevention methods” 35 (16.7) 
I did not know 
about the HPV 
vaccine 
38 (21.7) 
“What are the symptoms” 31 (14.8) I do not need the HPV vaccine 32 (18.3) 
“How is it spread” 23 (11.0) More than one reason 20 (11.4) 
“Dangers of HPV” 13 (6.2) Other 15 (8.6) 
“What are the chances it’ll affect me” 10 (4.8) It is too expensive 2 (1.1) 
“Treatment options” 4 (1.9) Cultural/religious reasons 2 (1.1) 
“Is there a cure” 3 (1.4) My Insurance does not cover it 1 (0.6) 
Total Respondents 210 (76.4**) Total Respondents 175 (63.7**) 
Note. * Indicates percentages based on total respondents in each column (n= 210 or 175). ** 
Indicates percentages based on the total sample (N=275). 
 
Many students in our study mentioned their 
general interest in protecting themselves. While 
50.8% of students were interested in learning 
more about HPV, 70% of students reported that 
a physician had not discussed the HPV vaccine 
with them. Additionally, 76% of students 
responded with a question when asked what they 
wanted to learn. With such a large percentage of 
students showing an interest in HPV education, 
having more physicians discuss the vaccine with 
children and parents could become a critical and 
effective aspect of HPV education campaigns 
(Safeer & Keenan, 2005).  This is further 
supported with the study’s key finding that there 
is a strong positive correlation between a 
physician discussing the HPV vaccine and the 
following variables: HPV knowledge, interest in 
learning more, and vaccine uptake. Another key 
finding was that students that had prior HPV 
knowledge were significantly more likely to 
receive the vaccine. Such findings emphasize the 
importance of promoting the role of physicians 
within HPV education campaigns.  
 
Few studies have examined HPV knowledge of 
both young men and women. This study found 
that there is a very significant gender gap in 
HPV discussion and vaccination rates, 
regardless of their risk of contracting HPV or 
their interest in learning more about HPV. More 
specifically, it was found that physicians were 
more likely to discuss the HPV vaccine with 
females and more females than males reported 
receiving the vaccine. As such HPV education 
campaigns should benefit from targeting both 
male and female adolescents in interventions 
tailored by gender. Future education campaigns 
should encourage physicians to discuss the 
vaccine with both male and female adolescent 
patients, as well as parents. With less than 10% 
of students reporting having received the full 
vaccine series, it has become increasingly 
important for children and parents to receive 
HPV information as soon as their child enters 
their early teens. Early vaccination ensures that 
children receive preventive care before being 
exposed to the virus, which will decrease the 
prevalence of HPV.  
 
Implications for this study include both the 
potential to decrease the gender gap in HPV 
knowledge and promote the initiation of the 
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HPV vaccine series among adolescents. 
Educating adolescents will also have the added 
benefit of educating parents, and research shows 
that parents not being educated are a hindrance 
to vaccination rates (Mergler et al., 2013). The 
sooner females are vaccinated, the lower the risk 
of developing chronic HPV infection and 
cervical cancer in the next 25 years (Vuyst, 
Clifford, Nascimento, Madeleine, & Franceschi, 
2009). By increasing HPV knowledge among 
the adolescent population, there will be a 
decreased exposure to HPV strains like 
HPV16/18, thereby helping to control the 
increasing rates of vulvar, vaginal, and anal 
carcinomas - particularly among women (Tsu, 
Murray, & Franceschi, 2012).   
 
Limitations 
One important limitation in this study was a lack 
of access to a wider range of schools within the 
district. Very few schools were willing to have 
their students surveyed, preventing expansion to 
other schools. The students surveyed were 
attending high school in a high income 
neighborhood and had access to a sex education 
course in year three; therefore the significant rise 
in HPV knowledge between age groups could be 
attributed to this confounding variable. Future 
studies should examine the role of sexual 
education courses on HPV knowledge and 
vaccine uptake, and compare schools with and 
without such curriculum on outcomes such as 
HPV knowledge and vaccine uptake. 
 
Conclusion 
In sum, our findings suggest that education, 
gender, race, and having discussed HPV with 
one’s physician play a crucial role in HPV 
vaccine uptake and initiation. Due to the 
increasing risk of HPV exposure among both 
young boys and girls, health professionals 
should be taking more extensive measures 
towards educating adolescents. HPV education 
campaigns among adolescent populations have 
not been working. Our findings suggest that both 
education and gender play a crucial role in HPV 
vaccine uptake and initiation. Physicians play a 
critical role in the rate of vaccine uptake among 
the adolescent population, and so should discuss 
HPV and the HPV vaccine to adolescents before 
the onset of sexual activity. Future education 
campaigns should target physicians and 
encourage them to discuss the vaccine with both 
their adolescent patients as well as their parents, 
both male and female.  
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